Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation1

Foxp3 expressing CD4+CD25+ regulatory T cells (Tregs) have been shown to prevent allograft rejection in clinical and animal models of transplantation. However, the role of Foxp3 in regulating Treg function, and the kinetics and mechanism of action of Tregs in inducing allograft tolerance in transplantation, are still not fully understood. Thus, we investigated the kinetics and function of Tregs in a mouse model of orthotopic corneal transplantation, the most common form of tissue grafting worldwide. In this study, using in vitro functional assays and in vivo Treg adoptive transfer assays, we show that far more relevant than Treg frequency is their level of Foxp3 expression, which is directly associated with the potential of Tregs to prevent allograft rejection by producing regulatory cytokines and suppressing effector T cell activation. In addition, our data clearly demonstrate that Tregs primarily suppress the induction of alloimmunity in regional draining lymph nodes rather than suppressing the effector phase of the immune response in the periphery. These findings provide new insights on Treg dynamics in transplantation, which are crucial for designing therapeutic strategies to modulate Treg function and to optimize Treg-based cell therapies for clinical translation.

[1]  K. Wood Regulatory T Cells in Transplantation , 2011, Transplantation proceedings.

[2]  J. Torras,et al.  Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. , 2008, Journal of the American Society of Nephrology : JASN.

[3]  G. Jhangri,et al.  FOXP3 Expression in Human Kidney Transplant Biopsies Is Associated with Rejection and Time Post Transplant but Not with Favorable Outcomes , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  K. Bocian,et al.  The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. , 2007, Transplantation proceedings.

[5]  C. Baan,et al.  Expression Patterns of Regulatory T‐Cell Markers in Accepted and Rejected Nonhuman Primate Kidney Allografts , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  G. Freeman,et al.  The Function of Donor versus Recipient Programmed Death-Ligand 1 in Corneal Allograft Survival1 , 2007, The Journal of Immunology.

[7]  D. San Segundo,et al.  Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors. , 2007, Transplantation proceedings.

[8]  Hua Yang,et al.  Hyperexpression of Foxp3 and IDO During Acute Rejection of Islet Allografts , 2007, Transplantation.

[9]  W. Weimar,et al.  Intragraft FOXP3 mRNA Expression Reflects Antidonor Immune Reactivity in Cardiac Allograft Patients , 2007, Transplantation.

[10]  J. Bluestone,et al.  CD4+CD25+ Regulatory T Cells in Transplantation: Progress, Challenges and Prospects , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  Nitin J. Karandikar,et al.  Transient regulatory T-cells: a state attained by all activated human T-cells. , 2007, Clinical immunology.

[12]  R. Colvin,et al.  Pathological and Clinical Correlates of FOXP3+ Cells in Renal Allografts during Acute Rejection , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  V. Kuchroo,et al.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.

[14]  Y. Wan,et al.  Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression , 2007, Nature.

[15]  T. Huizinga,et al.  Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells , 2007, European journal of immunology.

[16]  N. Câmara,et al.  FOXP3-positive regulatory cells inside the allograft and the correlation with rejection. , 2006, Transplantation proceedings.

[17]  S. Lira,et al.  Lymph Node Occupancy Is Required for the Peripheral Development of Alloantigen-Specific Foxp3+ Regulatory T Cells1 , 2005, The Journal of Immunology.

[18]  S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[19]  M. Dana,et al.  Relevance of the Direct Pathway of Sensitization in Corneal Transplantation Is Dictated by the Graft Bed Microenvironment1 , 2004, The Journal of Immunology.

[20]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[21]  K. Wood,et al.  Regulatory lymphocytes: Regulatory T cells in transplantation tolerance , 2003, Nature Reviews Immunology.

[22]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[23]  M. Karim,et al.  Regulatory T cells in transplantation. , 2002, Current opinion in immunology.

[24]  H. Waldmann,et al.  Identification of Regulatory T Cells in Tolerated Allografts , 2002, The Journal of experimental medicine.

[25]  R. Dana,et al.  Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative Grafts , 2002, The Journal of experimental medicine.

[26]  W. Weimar,et al.  FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients. , 2008, Transplant immunology.

[27]  O. Joffre,et al.  Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes , 2008, Nature Medicine.

[28]  H. Waldmann,et al.  Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.